ASH 2018: A Guide to the Latest for Blood-Born... - CLL Support

CLL Support

22,988 members39,473 posts

ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More

wmay13241 profile image
8 Replies

The American Society of Hematology (ASH) annual meeting is being held December 1-4, 2018 in San Diego, CA. There is a guide at: xconomy.com/national/2018/1...

Written by
wmay13241 profile image
wmay13241
To view profiles and participate in discussions please or .
Read more about...
8 Replies
BettinaB profile image
BettinaB

Thank you, very helpful!

Lola69 profile image
Lola69

Imbruvica saved my life!

Justasheet1 profile image
Justasheet1

Thanks.

Jm954 profile image
Jm954Administrator

I would love to go .......

Newdawn profile image
NewdawnAdministrator in reply to Jm954

Me too! 😊

Newdawn

Jm954 profile image
Jm954Administrator in reply to Newdawn

We could go together one year :)

Newdawn profile image
NewdawnAdministrator in reply to Jm954

😀 Sounds good to me!

Newdawn

HannahHugo profile image
HannahHugo

My wife’s haematologist from Melbourne, Australia attending this to hear more about ibrutinib plus rituximab combination. Wife starting on ibrutinib after he gets back for she didn’t respond positively to 2 cycles of FCR.

First diagnosed with NHL (SLL) in 2008, treated with CHOP+R then returned as CLL in 2013, treated with CVP+R, now returned 2018. Also been receiving IgG infusions regularly.

Let’s hope the ASH conference reports plenty of encouraging options.

Not what you're looking for?

You may also like...

ASH 2018 and More

Hi, This is the most exciting, hectic and rewarding time of the year for the CLL Society, as we are...

ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL

Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

Venetoclax was changed how we treat CLL, but it doesn't work for everyone and it doesn't always...

ASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)

Is venetoclax as safe and effective in the real world as compared to clinical trials? Read my ASH...

ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR

Hi friends, The early buzz at ASH 2018 was rightly about the ECOG trial that was presented on the...